BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28068465)

  • 1. One-Year Developmental Outcomes for Infants of Mothers With Bipolar Disorder.
    Santucci AK; Singer LT; Wisniewski SR; Luther JF; Eng HF; Sit DK; Wisner KL
    J Clin Psychiatry; 2017; 78(8):1083-1090. PubMed ID: 28068465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes.
    Santucci AK; Singer LT; Wisniewski SR; Luther JF; Eng HF; Dills JL; Sit DK; Hanusa BH; Wisner KL
    J Clin Psychiatry; 2014 Oct; 75(10):1088-95. PubMed ID: 25373117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal antipsychotic exposure and neuromotor performance during infancy.
    Johnson KC; LaPrairie JL; Brennan PA; Stowe ZN; Newport DJ
    Arch Gen Psychiatry; 2012 Aug; 69(8):787-94. PubMed ID: 22474072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Level of prenatal cocaine exposure and scores on the Bayley Scales of Infant Development: modifying effects of caregiver, early intervention, and birth weight.
    Frank DA; Jacobs RR; Beeghly M; Augustyn M; Bellinger D; Cabral H; Heeren T
    Pediatrics; 2002 Dec; 110(6):1143-52. PubMed ID: 12456912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mood symptoms in pregnant and postpartum women with bipolar disorder: a naturalistic study.
    Driscoll KE; Sit DKY; Moses-Kolko EL; Pinheiro E; Yang A; Ciolino JD; Eng HF; Luther JF; Clark CT; Wisniewski SR; Wisner KL
    Bipolar Disord; 2017 Jun; 19(4):295-304. PubMed ID: 28665044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bipolar disorder and psychotropic medication: Impact on pregnancy and neonatal outcomes.
    Wisner KL; Sit D; O'Shea K; Bogen DL; Clark CT; Pinheiro E; Yang A; Ciolino JD
    J Affect Disord; 2019 Jan; 243():220-225. PubMed ID: 30248632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor delays in MDMA (ecstasy) exposed infants persist to 2 years.
    Singer LT; Moore DG; Min MO; Goodwin J; Turner JJ; Fulton S; Parrott AC
    Neurotoxicol Teratol; 2016; 54():22-8. PubMed ID: 26806601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal lead and cadmium co-exposure and infant neurodevelopment at 6 months of age: the Mothers and Children's Environmental Health (MOCEH) study.
    Kim Y; Ha EH; Park H; Ha M; Kim Y; Hong YC; Kim EJ; Kim BN
    Neurotoxicology; 2013 Mar; 35():15-22. PubMed ID: 23220728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine.
    Smith LM; LaGasse LL; Derauf C; Newman E; Shah R; Haning W; Arria A; Huestis M; Strauss A; Della Grotta S; Dansereau LM; Lin H; Lester BM
    Neurotoxicol Teratol; 2011; 33(1):176-84. PubMed ID: 21256431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3 years.
    Wouldes TA; Lagasse LL; Huestis MA; Dellagrotta S; Dansereau LM; Lester BM
    Neurotoxicol Teratol; 2014; 42():77-84. PubMed ID: 24566524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographic and Clinical Characteristics, Including Subsyndromal Symptoms Across Bipolar-Spectrum Disorders in Adolescents.
    Salazar de Pablo G; Guinart D; Cornblatt BA; Auther AM; Carrión RE; Carbon M; Jiménez-Fernández S; Vernal DL; Walitza S; Gerstenberg M; Saba R; Lo Cascio N; Brandizzi M; Arango C; Moreno C; Van Meter A; Correll CU
    J Child Adolesc Psychopharmacol; 2020 May; 30(4):222-234. PubMed ID: 32083495
    [No Abstract]   [Full Text] [Related]  

  • 12. Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.
    Yang A; Ciolino JD; Pinheiro E; Rasmussen-Torvik LJ; Sit DKY; Wisner KL
    J Clin Psychiatry; 2017 May; 78(5):605-611. PubMed ID: 28570796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stunting and wasting are associated with poorer psychomotor and mental development in HIV-exposed Tanzanian infants.
    McDonald CM; Manji KP; Kupka R; Bellinger DC; Spiegelman D; Kisenge R; Msamanga G; Fawzi WW; Duggan CP
    J Nutr; 2013 Feb; 143(2):204-14. PubMed ID: 23256148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postpartum maternal mental health is associated with cognitive development of HIV-exposed infants in Zimbabwe: a cross-sectional study.
    Mebrahtu H; Simms V; Chingono R; Mupambireyi Z; Weiss HA; Ndlovu P; Malaba R; Cowan FM; Sherr L
    AIDS Care; 2018 Jun; 30(sup2):74-82. PubMed ID: 29848008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodevelopmental effects of prenatal exposure to psychotropic medications.
    Gentile S
    Depress Anxiety; 2010 Jul; 27(7):675-86. PubMed ID: 20583298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major depressive disorder during pregnancy: Psychiatric medications have minimal effects on the fetus and infant yet development is compromised.
    Gustafsson HC; Goodman SH; Feng T; Choi J; Lee S; Newport DJ; Knight B; Pingeton B; Stowe ZN; Monk C
    Dev Psychopathol; 2018 Aug; 30(3):773-785. PubMed ID: 30068426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mothers with and without bipolar disorder and their infants: group differences in mother-infant interaction patterns at three months postpartum.
    Anke TMS; Slinning K; Moe V; Brunborg C; Siqveland TS; Skjelstad DV
    BMC Psychiatry; 2019 Sep; 19(1):292. PubMed ID: 31533800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect.
    Hanley GE; Brain U; Oberlander TF
    Early Hum Dev; 2013 Aug; 89(8):519-24. PubMed ID: 23384962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal exposure to organohalogen compounds and children's mental and motor development at 18 and 30 months of age.
    Ruel MVM; Bos AF; Soechitram SD; Meijer L; Sauer PJJ; Berghuis SA
    Neurotoxicology; 2019 May; 72():6-14. PubMed ID: 30664974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-Month, Prospective, Randomized Controlled Trial of Customized Adherence Enhancement Versus Bipolar-Specific Educational Control in Poorly Adherent Individuals With Bipolar Disorder.
    Sajatovic M; Tatsuoka C; Cassidy KA; Klein PJ; Fuentes-Casiano E; Cage J; Aebi ME; Ramirez LF; Blixen C; Perzynski AT; Bauer MS; Safren SA; Levin JB
    J Clin Psychiatry; 2018 Sep; 79(6):. PubMed ID: 30256551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.